San Francisco, CA — TrialWire, an AI-powered clinical trial patient recruitment

platform serving sponsors and contract research organizations (CROs), today

announced it has been named the AI-Powered Clinical Trial Patient Recruitment

Solutions Company of the Year 2026 by Healthcare Tech Outlook, a leading

healthcare technology knowledge network. The award was determined following an

evaluation by a panel of C-level executives, industry thought leaders, and the

publication’s editorial board, informed by nominations received from subscribers.

TrialWire’s platform enables sponsors and CROs from study start-up or to reboot stalled

studies to active patient screening within 24 hours. Unlike traditional database-driven

recruitment, the platform identifies potential participants in real time based on active,

health-related online intent and expressed therapeutic area interest, engaging

individuals when they are already motivated to explore solutions. Once identified,

participants move through an AI-powered screening agent that adapts to how people

communicate about their health, ensuring highly qualified candidates for site-level

assessment rather than prematurely excluding them.

“Speed only matters if it holds up under real site conditions. If recruitment

creates more work for coordinators or sends patients without sufficient

context or timelines, then timelines don’t improve. We focus on building

speed that sites can sustain”. Susan Fitzpatrick Napier, CEO TrialWire.

The platform is built on Salesforce Health Cloud, ensuring enterprise-grade data

protection and HIPAA compliance standards that allow studies to launch quickly without

introducing governance risk. Role-based access ensures that sponsors, CROs, and

sites see only the information relevant to their role in the study process, maintaining

consistent data governance across the trial lifecycle.

TrialWire’s site-centered approach extends pre-screening and scheduling workflows

directly into site coordination. Participants who complete initial screening enter secure

site portals with relevant context already attached, allowing coordinators to focus on

confirmation and progression rather than reconstruction. The platform’s success-based

pricing model—tied to enrolled participants rather than referrals—reflects a risk-share

philosophy that aligns TrialWire’s accountability with clinical trial outcomes.

The award reflects TrialWire’s growing reputation among sponsors, CROs, and industry

peers for delivering a AI powered patient recruitment engine that is both rapid and

sustainable—qualities increasingly critical as clinical development timelines compress

and site capacity remains constrained.

About TrialWire

TrialWire is an AI-powered clinical trial patient recruitment platform designed to help

sponsors and CROs accelerate enrolment, activating within 24 hours in an era where

speed, precision are non-negotiable. Advanced AI algorithms identify people online

searching for health solutions to deliver highly pre-screened candidates to site-aligned

workflows in minutes not months. The platform is built on Salesforce Health Cloud and

operates on a success-based model tied to enrolment of participants. Privacy-be-design

architecture guarantees compliance with global data protection standards, including

GDPR and HIPAA. With operations across North America, Europe, Asia Pacific,

TrialWire helps sponsors and CROs meet critical milestones and reduce execution risk

to help accelerate access to potentially life changing therapies.

About Healthcare Tech Outlook

Healthcare Tech Outlook (ISSN 2691-3933) is a healthcare technology knowledge

network that recognizes outstanding companies and solutions across the healthcare

technology landscape. Its annual awards are determined through subscriber

nominations and evaluation by a panel of C-level executives, industry thought leaders,

and an editorial board.